Bicarbonate

Bicarbonate

SCHEMBL7713688

O=C([O-])O.O=C([O-])[O-].[H+].[Na+].[Na+]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA4 P22748 6/20 0.50
FAHD1 Q6P587 1/20 0.50
CA1 P00915 3/20 0.46
MEN1 O00255 1/20 0.40
LDHA P00338 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 2/20 0.38
CASP1 P29466 1/20 0.38
CA2 P00918 2/20 0.36
CA9 Q16790 1/20 0.36
FFAR3 O14843 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL15666483 1.00 CA4 (0.50) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL19664202 0.95 CA4 (0.55) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL931293 0.95
Bicarbonate SCHEMBL222993 0.95 CA4 (0.55) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL4807761 0.95 CA4 (0.55) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL10379498 0.90 CA4 (0.50) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL11403647 0.90 CA4 (0.50) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL3395196 0.90 CA4 (0.50) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL7983250 0.90 CA4 (0.50) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL8421151 0.90 CA4 (0.50) CA4FAHD1CA1MEN1LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295191-A1 A POLYESTER MOLDING COMPRISING A METAL-ORGANIC FRAMEWORK HAVING A LOW OUTGASSING OF VOLATILE ORGANIC COMPOUNDS BASF SE (DE) 2023-09-21 US disclosed
EP-4188993-A1 A POLYESTER MOLDING COMPRISING A METAL-ORGANIC FRAMEWORK HAVING A LOW OUTGASSING OF VOLATILE ORGANIC COMPOUNDS BASF SE (DE) 2023-06-07 EP disclosed
WO-2022029078-A1 A POLYESTER MOLDING COMPRISING A METAL-ORGANIC FRAMEWORK HAVING A LOW OUTGASSING OF VOLATILE ORGANIC COMPOUNDS BASF SE (DE) 2022-02-10 WO disclosed
US-6365185-B1 ORAL TABLET FOR DELIVERING BENEFICIAL AGENT TO MAMMAL COMPRISING CORE COMPARTMENT HAVING BENEFICIAL AGENT SURROUNDED BY UNITARY SELF-DESTRUCTING SHELL COMPRISING PLURALITY OF DISINTEGRANT PARTICLES DISPERSED WITHIN SEMIPERMEABLE MATRIX UNIVERSITY OF CINCINNATI 2002-04-02 US disclosed
EP-0929514-A1 PROCESS FOR THE PREPARATION OF FLUOXETINE EGIS GYOGYSZERGYAR RT. (HU) 1999-07-21 EP disclosed
WO-1998011054-A1 PROCESS FOR THE PREPARATION OF FLUOXETINE EGIS Gyógyszergyár Rt. (HU) 1998-03-19 WO disclosed
US-3995018-A Method of binding immunoglobulin employing a polypeptide from microorganisms PHARMACIA AKTIEBOLAG (SW) 1976-11-30 US disclosed